Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Randomized clinical trials in soft tissue sarcoma.

Martin D Mccarter1, David P Jaques, Murray F Brennan

  • 1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

Surgical Oncology Clinics of North America
|April 4, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II Trial.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

CLO26-116: Epigenetic Modulation Using Combined oral Decitabine/Cedazuridine (DEC-C) and Nivolumab in Unresectable or Metastatic Mucosal Melanoma: A Phase Ib/II Trial.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Trends and Outcomes of Surgical Reconstruction of the IVC after Oncologic Resection.

Journal of the American College of Surgeons·2026
Same author

Lymphoid B cells upregulate HIV-1 ex vivo and are linked to its expression in vivo.

PLoS pathogens·2025
Same author

Human M-MDSCs impair neutrophil migration in the infectious microenvironment.

Journal of leukocyte biology·2025
Same author

From Early Detection To Advanced Therapies: How Circulating Tumor DNA Is Transforming the Care of Colorectal Cancer.

Current oncology reports·2025

Limb-sparing surgery with radiation offers equivalent local control to amputation for soft tissue sarcoma. Adjuvant radiation improves outcomes, but chemotherapy

Area of Science:

  • Oncology
  • Surgical Oncology
  • Radiation Oncology

Background:

  • Soft tissue sarcoma treatment relies on evidence-based decision-making.
  • Optimal management strategies require evaluation of prospective randomized controlled trials.

Purpose of the Study:

  • To synthesize findings from high-quality clinical trials on soft tissue sarcoma.
  • To guide physicians in evidence-based treatment choices for soft tissue sarcoma.

Main Methods:

  • Review of prospective randomized controlled clinical trials for soft tissue sarcoma.
  • Analysis of data on surgical techniques, radiation therapy, and chemotherapy.

Main Results:

  • Limb-sparing surgery with adjuvant radiation is equivalent to radical amputation for local disease control.

Related Experiment Videos

  • Adjuvant radiation therapy (external beam and brachytherapy) significantly improves local control after complete surgical resection.
  • Most deaths result from systemic disease, not local recurrence, indicating local control does not guarantee overall survival.

    • Conclusions:

    • Limb-sparing surgery combined with adjuvant radiation is a preferred alternative to amputation for local control.
    • Adjuvant radiation is crucial for improving local control in extremity soft tissue sarcoma.
    • The role and benefit of adjuvant chemotherapy, including doxorubicin-based regimens, remain uncertain, with any survival benefit likely minimal.